HSIC on Nasdaq

Henry Schein

Logo: henryschein.com5

American healthcare company

Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories.3 From Wikipedia, CC BY-SA 4.0

$86.28 down 0.71 (0.82%)Price as of Oct 16, 2026 at 19:58 UTC

Last updated Oct 18, 2026.

Overview

1932Founded1

Compare with Patterson Companies or Owens & Minor, or pick any stock.

  • TickerHSIC on Nasdaq1
  • IndustryWholesale-Medical, Dental & Hospital Equipment & Supplies1
  • HeadquartersMelville1
  • Founded inQueens1
  • Websitewww.henryschein.com
  • Legal formDelaware corporation, Public limited company (Belgium)1
  • Incorporated inDE6
  • Business address135 Duryea Rd, Melville, Ny 117476
  • Filer categoryLarge accelerated filer6

See how the biggest companies compare on our leaderboards

Henry Schein, Inc. is an American distributor of health care products and services, with operations in 33 countries and territories. It is the world's largest provider of health care solutions to office-based dental and medical practitioners.3

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

31.1%Gross margin8
5.0%Operating margin8
3.0%Net margin8
4.0%Revenue growth, 20258
12.3%Return on equity8

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Business segments

Global Distribution and Value-Added Services brought in 84% of the revenue Henry Schein broke down this way in fiscal 2025.

  1. Global Distribution and Value-Added Services$11.1B884%up 4% from 2024
  2. Global Specialty Products$1.4B811%up 6% from 2024
  3. Global Technology$675.0M85%up 7% from 2024
Business segments by year
Business segments202320242025
Global Distribution and Value-Added Services$10.6B$10.8B$11.1B
Global Specialty Products$1.2B$1.3B$1.4B
Global Technology$602.0M$630.0M$675.0M

Regions

United States brought in 69% of the revenue Henry Schein broke down this way in fiscal 2025.

  1. United States$9.1B869%up 3% from 2024
  2. Outside the United States$4.1B831%up 6% from 2024
Regions by year
Regions202320242025
United States$8.7B$8.8B$9.1B
Outside the United States$3.7B$3.8B$4.1B

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Cost of revenue69¢$9.1B
  • Selling, general and admin23¢$3.1B
  • Other costs3¢$347.0M
  • Interest1¢$150.0M
  • Income tax1¢$126.0M
  • Profit3¢$398.0M

Out of $13.2B in revenue.8

Where each dollar of operating cash went, fiscal 2025

  • Share buybacks100¢$850.0M

Out of $712.0M of cash from operations. Spending exceeded cash from operations; the rest came from savings or borrowing.8

Financial statements

Revenue91011128$13.2B in 2025+32% since 2019
0$5.0B$10.0B$15.0B2019: $10.0B$10.0B20192020: $10.1B$10.1B2020+1%2021: $12.4B$12.4B2021+23%2022: $12.6B$12.6B2022+2%2023: $12.3B$12.3B2023−2%2024: $12.7B$12.7B2024+3%2025: $13.2B$13.2B2025+4%
Gross profit91011128$4.1B in 2025+33% since 2019
0$2.0B$4.0B$6.0B2019: $3.1B$3.1B20192020: $2.8B$2.8B2020−9%2021: $3.7B$3.7B2021+30%2022: $3.8B$3.8B2022+4%2023: $3.9B$3.9B2023+1%2024: $4.0B$4.0B2024+4%2025: $4.1B$4.1B2025+2%
Operating income91011128$653.0M in 2025−9% since 2019
0$250.0M$500.0M$750.0M$1.0B2019: $718.3M$718.3M20192020: $535.0M$535.0M2020−26%2021: $852.0M$852.0M2021+59%2022: $747.0M$747.0M2022−12%2023: $615.0M$615.0M2023−18%2024: $621.0M$621.0M2024+1%2025: $653.0M$653.0M2025+5%
Net income91011128$398.0M in 2025−43% since 2019
0$200.0M$400.0M$600.0M$800.0M2019: $694.7M$694.7M20192020: $404.0M$404.0M2020−42%2021: $631.0M$631.0M2021+56%2022: $538.0M$538.0M2022−15%2023: $416.0M$416.0M2023−23%2024: $390.0M$390.0M2024−6%2025: $398.0M$398.0M2025+2%

Every line of the income statement as filed: the last 3 fiscal years, latest first.8

Period ending2025-12-312024-12-312023-12-31
Net sales$13.2B$12.7B$12.3B
Cost of sales$9.1B$8.7B$8.5B
Gross profit$4.1B$4.0B$3.9B
Selling, general and administrative$3.1B$3.0B$3.0B
Depreciation and amortization$263.0M$251.0M$209.0M
Restructuring and related costs$105.0M$110.0M
Operating income$653.0M$621.0M$615.0M
Interest income$33.0M$24.0M$17.0M
Interest expense-$150.0M-$131.0M-$87.0M
Other, net-$3.0M-$1.0M-$3.0M
Income before taxes, equity in earnings of affiliates and noncontrolling interests$533.0M$513.0M$542.0M
Income taxes-$126.0M-$128.0M-$120.0M
Equity in earnings of affiliates, net of tax$12.0M$13.0M$14.0M
Net Income$419.0M$398.0M$436.0M
Less: Net income attributable to noncontrolling interests-$21.0M-$8.0M-$20.0M
Net income attributable to Henry Schein, Inc.$398.0M$390.0M$416.0M
Basic (in dollars per share)$3.29$3.07$3.18
Diluted (in dollars per share)$3.27$3.05$3.16
Basic (in shares)120.8M shares126.8M shares130.6M shares
Diluted (in shares)121.7M shares127.8M shares131.7M shares

Compare Henry Schein with another company

The story

In 1932, Henry Schein, a graduate of Columbia University College of Pharmacy, borrowed $500 and opened a pharmacy in Queens, New York. The company expanded into dental supplies in the 1960s, and by the late 1980s, Henry Schein held approximately 10 percent of the dental-supply market. Marvin Schein, Henry Schein's son, took over management of daily operations in 1971.

In 1978, founder Henry Schein's son Jay Schein became CEO of the company. When Jay Schein died of cancer in 1989, Stanley Bergman took over as CEO. Bergman was born in South Africa and came to New York in 1976, where he became an accountant. In 1980, he joined Henry Schein and was promoted to CFO.

Henry Schein Inc. filed with the U.S. Securities and Exchange Commission in 1995 to sell 6.2 million shares in an initial public offering with William Blair & Company as the lead underwriter. The IPO raised $72.8 million and began trading on the Nasdaq. By 1996, the company was up to $1.4 billion in sales and $29 million in profit under Bergman's leadership. That year, the company made seventeen acquisitions.

In August 1997, Henry Schein Inc. agreed to buy Sullivan Dental Products Inc. for approximately $318 million. The purchase made the company the world's largest distributor of dental equipment and supplies. By that point, Henry Schein had made 16 acquisitions in 1997. Also in 1997, Henry Schein acquired New York-based medical-products distributor Micro BioMedics Inc as well as Dentrix Dental Systems.

Henry Schein announced the acquisition of demedis GmbH and Euro Dental Holding GmbH in June 2004. In November 2009, it was announced that Henry Schein Inc. and Butler Animal Health Supply would be launching joint venture Butler Schein Animal Health, the largest veterinary sales and distribution company in the United States. Butler Schein Animal Health was rebranded as Henry Schein Animal Health in 2013. Between 1989 and 2016, Henry Schein purchased approximately 200 companies. The company's chief executive officer, Stanley Bergman, was announced as Chief Executive Magazine's CEO of the Year in May 2017.

In 2018, the FTC accused Benco Dental, Patterson Companies, and Henry Schein of violating antitrust laws. In October 2019, the FTC's Chief Administrative Law Judge dismissed the claims against Henry Schein while finding that Benco and Patterson violated U.S. antitrust laws.

In February 2019, Henry Schein spun off the company's animal health business and merged it with Vets First Choice to form a new company. The new company is established as Covetrus.

Henry Schein Inc. was one of the six main defendants in lawsuits with state and local governments of the opioid epidemic in the United States. The company was dismissed as a defendant in October 2019 in the bellwether Summit County, Ohio litigation.

Read the full text

In July 2022, Henry Schein acquired Condor Dental, a dental distribution company.

In April 2023, Henry Schein acquired Biotech Dental, a provider of dental implants, clear aligners, and digital dental software, based in Salon-de-Provence, France.

In July 2023, Henry Schein acquired S.I.N Implant System, a major provider of dental implants in Brazil.

On October 14, 2023, Henry Schein reported a major hack into its core systems, which included investor information, and payroll data - amounting to 35 Terabytes of data being exfiltrated from the company. This resulted in its applications and e-commerce site being unavailable for several days.

In July 2025, Henry Schein announced that Stanley Bergman would be stepping down as CEO at the end of 2025, however he will continue to serve as chairman of the board. In January 2026 the company announced Bergman's successor as Frederick Lowery, Executive Vice President and President, Laboratory Products and BioProduction at Thermo Fisher Scientific.

In 2025, Henry Schein ranked 333rd by revenue on the Fortune 500 list and 34th within the healthcare sector.

From Wikipedia’s article on Henry Schein, shared under CC BY-SA 4.0.7

Leadership

Who has led Henry Schein, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Stanley M. Bergman2006–2012
  2. Lonnie Shoff2012–2016
  3. James P. Breslawski2013–2018
  4. Karen Prange2016–2018
  5. Bradford C. Connett2021–2024
  6. David B. Brous Jr.2021–2023
  7. Andrea Albertini2024–2025
  8. Thomas C. Popeck2025–2026
  9. Frederick M. Lowery2026–now

Chair

  1. Stanley M. Bergman2006–now

President

  1. James P. Breslawski2006
  2. Michael Racioppi2006–2008
  3. Michael Zack2006–2013
  4. Robert Minowitz2013–2016
  5. Bridget A. Ross2017

Chief financial officer

  1. Steven Paladino2006–2022
  2. Ronald N. South2022–now

Chief operating officer

  1. James P. Breslawski2006–2013
  2. Michael S. Ettinger2023–now
197019801990200020102020
Board members and other officers (44)

Products and brands

Operations

Dental

In 1997, Henry Schein acquired Sullivan Dental Products and Dentrix Dental Systems, making it the world's largest distributor of dental equipment and supplies.

Dentrix Ascend, is a cloud-based dental practice management software platform developed by Henry Schein One for dental offices. The software is accessible through a web browser and includes tools of scheduling, billing, patient records, imaging, and practice management.

Henry Schein established the Henry Schein Dental Business Institute in March 2015 to teach owners and operators of dental practices the fundamentals of business. The first class to complete the program graduated in March 2016. Henry Schein also launched the Henry Schein Digital Dentistry Program at Temple University's Maurice H. Kornberg School of Dentistry in 2016.

In May 2016, Henry Schein's entity Dentrix presented the DEXIS software's ability to integrate X-rays into a patient's chart. Zahn Dental, Henry Schein's laboratory supply business, acquired Custom Automated Prosthetics in June 2016. The acquisition enabled Henry Schein to expand its prosthetic offerings.

Read the full text

In August 2019, Henry Schein acquired a majority equity stake in Cliniclands, a distributor serving dental practices throughout Sweden, Denmark, and Norway.

In May 2021, Henry Schein announced it acquired an 80% ownership position in Jarvis Analytics, a software company that develops comprehensive data analytics tools for dental practitioners.

In June 2021, Henry Schein acquired a 70% ownership position in eAssist Dental Solutions (eAssist), the developer of a virtual dental billing outsourcing service.

In August 2022, Henry Schein acquired Midway Dental Supply, a full-service dental distributor serving across the Midwestern United States.

In January 2023, Henry Schein announced its subsidiary, eAssist Dental Solutions (eAssist), acquired a majority interest in Unitas PPO Solutions (Unitas), a service provider that works with dental practices to assess their commercial insurance participation, set competitive fee-for-service rates, and negotiate contracted reimbursement with commercial insurers.

In July 2024, Henry Schein acquired abc dental AG, a full-service dental distributor offering consumables, equipment, and technical service to general practitioners, specialists, and dental laboratories in Switzerland.

Henry Schein One

In July 2018, Henry Schein and Internet Brands completed a joint venture to form Henry Schein One. The new company delivers integrated dental technology to help improve practice management and marketing as well as patient communication. Since the formation, Henry Schein One has included Dentrix, Dentrix Ascend, Dentalplans.com, Demandforce, Sesame Communications, and Officite as part of its portfolio of dental technology products.

In July 2019, Henry Schein One acquired Elite Computer Italia S.r.L. (Elite), a full-service software company that delivers practice management solutions to dental practices in Italy.

In November 2022, Henry Schein One announced a partnership with VideaHealth, a dental AI platform. As a result, Henry Schein One introduced Dentrix Detect AI, an AI-enabled X-Ray analysis tool. The integration with VideaHealth's FDA-cleared computer-assisted detection (CADe) device can help oral health professionals use AI in dental practices.

In December 2023, Henry Schein One was named to Utah Business Magazine's Best Companies to Work For list.

Medical

In November 2014, Henry Schein Medical announced a strategic arrangement with Cardinal Health. Cardinal Health's physician office-sales organization consolidated into Henry Schein Medical.

In March 2019, Henry Schein acquired North American Rescue (NAR), the leading provider of survivability and casualty-care medical products to the defense and public-safety markets.

In January 2021, Henry Schein acquired a majority ownership position in Prism Medical Products, LLC (PRISM), a nationwide provider of specialty home medical supplies with a core competency in advanced wound care products.

In October 2023, Henry Schein acquired Shield Healthcare, Inc., a supplier of homecare medical products delivered directly to patients in their homes.

In April 2024, Henry Schein acquired TriMed, a developer of orthopedic devices for lower extremities (foot and ankle) and upper extremities (hand and wrist).

In January 2025, Henry Schein acquired all of the assets of Acentus, a medical supplier specializing in Continuous Glucose Monitors (CGMs).

Former division

Animal health

Henry Schein has spun off this division in early 2019 produces software that is used in veterinary practices designed to improve communication and data management including the online cloud-based application, Rapport. In February 2016, Henry Schein released Axis-Q, a software application designed to ease the recording and access of veterinary medical records.

From Wikipedia’s article on Henry Schein, shared under CC BY-SA 4.0.7

Subsidiaries and ownership

Subsidiaries

  • Dentalplans.com
  • HENRY SCHEIN

From Wikidata.1

Former names

  • SCHEIN HENRY INCMay 13, 1996 to Jun 19, 20066

Timeline

  1. Mar 2, 2026New chief executive Frederick M. Lowery becomes CEO16
  2. Feb 21, 2025New chief executive Thomas C. Popeck becomes CEO17
  3. May 31, 2024New chief executive Andrea Albertini becomes CEO18
  4. Sep 24, 2021New chief executive Bradford C. Connett becomes CEO19
  5. Sep 24, 2021New chief executive David B. Brous Jr. becomes CEO20
  6. May 20, 2016New chief executive Karen Prange becomes CEO21
  7. Dec 18, 2013New chief executive James P. Breslawski becomes CEO22
  8. Sep 27, 2012New chief executive Lonnie Shoff becomes CEO23
  9. Mar 3, 2006New chief executive Stanley M. Bergman becomes CEO24
  10. Nov 3, 1995Went public Listed on NASDAQ1
  11. 1932Founded Founded in Queens1

Filings

486 filings to the SEC since October 2021: 5 annual reports, 15 quarterly reports, 54 major events, 298 insider forms, 32 large holders, 82 other. The latest 20:

  1. Oct 8, 20268-K EDGAR
  2. Sep 22, 20268-K EDGAR
  3. Sep 9, 20264 EDGAR
  4. Aug 14, 2026144 EDGAR
  5. Aug 6, 2026SCHEDULE 13G EDGAR
  6. Aug 4, 202610-Q QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D) EDGAR
  7. Aug 4, 20268-K CURRENT REPORT FILING EDGAR
  8. Jul 30, 20268-K EDGAR
  9. Jun 30, 2026144 EDGAR
  10. Jun 18, 202611-K ANNUAL REPORT OF EMPLOYEE STOCK PURCHASE, SAVINGS, AND SIMILAR PLANS EDGAR
  11. Jun 16, 2026144 EDGAR
  12. Jun 15, 20264 EDGAR
  13. May 29, 2026SD SPECIALIZED DISCLOSURE REPORT FILED PURSUANT TO SECTION 1502 OF THE DODD-FRANK W EDGAR
  14. May 28, 20263 EDGAR
  15. May 26, 20264/A EDGAR
  16. May 22, 20264 EDGAR
  17. May 22, 20268-K EDGAR
  18. May 21, 20264 EDGAR
  19. May 12, 20264 EDGAR
  20. May 12, 2026DEFA14A EDGAR

The 486 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last three years, summarized. The full record is on SEC EDGAR.

Insider trades and holders

Large holders

Investors who own more than 5% must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively. 32 such filings since October 2021, the latest 10:

  1. Aug 6, 2026SCHEDULE 13G
  2. Apr 30, 2026SCHEDULE 13G
  3. Mar 27, 2026SCHEDULE 13G/A
  4. Mar 10, 2026SCHEDULE 13D/A
  5. Dec 9, 2025SCHEDULE 13D/A
  6. Dec 3, 2025SCHEDULE 13G/A
  7. Nov 6, 2025SCHEDULE 13D/A
  8. Oct 31, 2025SCHEDULE 13G/A
  9. Oct 30, 2025SCHEDULE 13G/A
  10. Aug 15, 2025SCHEDULE 13D/A

From Forms 4 and Schedules 13D and 13G filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 100. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Kohlberg Kravis Roberts & Co. L.P.15,652,032$1.3B23.9%No change
Fmr LLC7,553,901$630.9M0.0%+1,831,752
BlackRock, Inc.7,024,663$586.7M0.0%+1,674
Artisan Partners Limited Partnership6,467,467$540.2M0.9%−105,556
Vanguard Capital Management LLC6,346,669$530.1M0.0%−76,498
Jpmorgan Chase & Co4,342,929$366.4M0.0%−219,583
State Street Corp4,305,276$359.6M0.0%−73,705
Vanguard Portfolio Management LLC4,133,442$345.2M0.0%−61,478
American Century Companies Inc3,457,175$288.7M0.1%−137,184
Dimensional Fund Advisors LP3,394,242$283.5M0.1%+521,238
Southpoint Capital Advisors LP3,300,000$275.6M6.3%+100,000
Invesco Ltd.3,150,237$263.1M0.0%−1,736,246
Citadel Advisors LLC2,921,103$244.0M0.1%+2,887,920
Geode Capital Management, LLC2,729,030$227.5M0.0%−41,220
Palestra Capital Management LLC2,446,691$204.3M6.9%−965,976
Bank Of Montreal /can/2,115,510$176.7M0.1%+71,540
Morgan Stanley2,100,819$175.5M0.0%+674,121
Fiduciary Management Inc /wi/1,817,353$151.8M2.2%−136,730
Lyrical Asset Management LP1,467,351$122.6M1.6%−77,091
UBS Group AG1,336,843$111.7M0.0%+281,377
Swedbank AB1,310,822$109.5M0.1%No change
M.D. Sass, LLC1,286,942$107.5M7.1%+13,626
Snyder Capital Management L P1,285,225$107.3M1.9%+16,416
Schroder Investment Management Group1,272,537$107.3M0.1%−241,848
Norges Bank1,237,832$103.4M0.0%New

13F reports cover disclosed long positions in U.S. stocks only.

Members of Congress who traded it

10 trades disclosed by members of Congress. “Vs S&P since” is the stock’s change since the trade minus the S&P 500’s.

DateMemberTradeAmountVs S&P sinceFiling
Apr 8, 2025Robert P. Bresnahan, Jr.Republican, HouseBuy$1,001 - $15,000−16.7%Report
Apr 1, 2025Julie JohnsonDemocratic, HouseSale$1,001 - $15,000+11.6%Report
Mar 31, 2025Gilbert Ray Cisneros, Jr.Democratic, HouseSale$1,001 - $15,000+11.0%Report
Jan 6, 2022Susan M. CollinsRepublican, SenateSale$15,001 - $50,000+53.2%Report
Aug 7, 2020Lois FrankelDemocratic, HouseSale$1,001 - $15,000+102.4%Report
Apr 17, 2018Thomas R. SuozziDemocratic, HouseSale$15,001 - $50,000+129.5%Report
Mar 29, 2018Thomas R. SuozziDemocratic, HousePartial sale$1,001 - $15,000+128.3%Report
Dec 6, 2017Thomas R. SuozziDemocratic, HouseSale$15,001 - $50,000+129.1%Report
Dec 6, 2017Thomas R. SuozziDemocratic, HousePartial sale$15,001 - $50,000+129.1%Report
Aug 17, 2017Thomas R. SuozziDemocratic, HouseBuy$15,001 - $50,000−186.7%Report

Members report amounts as ranges, not exact figures. Returns are price-only (no dividends).

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
    Yahoo FinanceHSIC quote
  5. 5
    Company websiteHenry Schein logo
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32
  33. 33
  34. 34
  35. 35
  36. 36
  37. 37
  38. 38
  39. 39
  40. 40
  41. 41
  42. 42
  43. 43
  44. 44
  45. 45
  46. 46
  47. 47
  48. 48
  49. 49
  50. 50
  51. 51
  52. 52
  53. 53
  54. 54
  55. 55
  56. 56
  57. 57
  58. 58
  59. 59
  60. 60
  61. 61
  62. 62
  63. 63
  64. 64
  65. 65
  66. 66
  67. 67
  68. 68
  69. 69
  70. 70
  71. 71